InvestorsHub Logo
Followers 33
Posts 2248
Boards Moderated 0
Alias Born 10/13/2010

Re: None

Thursday, 04/04/2024 9:35:19 AM

Thursday, April 04, 2024 9:35:19 AM

Post# of 26218
Good news: Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract.
Bullish
Bullish